These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29569727)

  • 21. Indirect methods of comparison of the safety of ferric derisomaltose, iron sucrose and ferric carboxymaltose in the treatment of iron deficiency anemia.
    Pollock RF; Biggar P
    Expert Rev Hematol; 2020 Feb; 13(2):187-195. PubMed ID: 31928094
    [No Abstract]   [Full Text] [Related]  

  • 22. Intravenous Iron Use in the Care of Patients with Kidney Disease.
    Macdougall IC
    Clin J Am Soc Nephrol; 2019 Oct; 14(10):1528-1530. PubMed ID: 31175103
    [No Abstract]   [Full Text] [Related]  

  • 23. Intravenous iron isomaltoside improves hemoglobin concentration and iron stores in female iron-deficient blood donors: a randomized double-blind placebo-controlled clinical trial.
    Gybel-Brask M; Seeberg J; Thomsen LL; Johansson PI
    Transfusion; 2018 Apr; 58(4):974-981. PubMed ID: 29424441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous iron isomaltoside versus oral iron supplementation for treatment of iron deficiency in pregnancy: protocol for a randomised, comparative, open-label trial.
    Markova V; Hansen R; Thomsen LL; Pinborg A; Moos T; Holm C
    Trials; 2020 Aug; 21(1):742. PubMed ID: 32843079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease.
    Wikström B; Bhandari S; Barany P; Kalra PA; Ladefoged S; Wilske J; Thomsen LL
    J Nephrol; 2011; 24(5):589-96. PubMed ID: 21240875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel disease.
    Reinisch W; Altorjay I; Zsigmond F; Primas C; Vogelsang H; Novacek G; Reinisch S; Thomsen LL
    Scand J Gastroenterol; 2015; 50(10):1226-33. PubMed ID: 25900645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A systematic literature review and indirect comparison of iron isomaltoside and ferric carboxymaltose in iron deficiency anemia after failure or intolerance of oral iron treatment.
    Pollock RF; Muduma G
    Expert Rev Hematol; 2019 Feb; 12(2):129-136. PubMed ID: 30689458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conversion of haemodialysis patients from iron sucrose to iron isomaltoside: a real-world experience.
    Jesus-Silva JA; Lamplugh A; Dhada S; Burton JO; Bhandari S
    BMC Nephrol; 2020 Jun; 21(1):212. PubMed ID: 32493240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy.
    al-Momen AK; al-Meshari A; al-Nuaim L; Saddique A; Abotalib Z; Khashogji T; Abbas M
    Eur J Obstet Gynecol Reprod Biol; 1996 Nov; 69(2):121-4. PubMed ID: 8902444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark.
    Pollock RF; Muduma G
    Adv Ther; 2018 Dec; 35(12):2128-2137. PubMed ID: 30456520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iron sucrose or ferric gluconate?
    Duffy CI
    Am J Kidney Dis; 2001 Dec; 38(6):1442. PubMed ID: 11728988
    [No Abstract]   [Full Text] [Related]  

  • 32. Intravenous ferric derisomaltose for the treatment of iron deficiency anemia.
    Auerbach M; Henry D; DeLoughery TG
    Am J Hematol; 2021 Jun; 96(6):727-734. PubMed ID: 33580972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Iron Deficiency Anemia in Pregnancy with Intravenous versus Oral Iron: Systematic Review and Meta-Analysis.
    Govindappagari S; Burwick RM
    Am J Perinatol; 2019 Mar; 36(4):366-376. PubMed ID: 30121943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of the efficacy of intravenous iron III-hydroxide saccharate for treating adult patients with iron deficiency anemia].
    Cançado RD; Brasil SA; Noronha TG; Chiattone CS
    Rev Assoc Med Bras (1992); 2005; 51(6):323-8. PubMed ID: 16444338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of parenteral iron in children with inflammatory bowel disease.
    Papadopoulos M; Patel D; Korologou-Linden R; Goto E; Soondrum K; Fell JME; Epstein J
    Br J Clin Pharmacol; 2018 Apr; 84(4):694-699. PubMed ID: 29266387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route.
    Bayoumeu F; Subiran-Buisset C; Baka NE; Legagneur H; Monnier-Barbarino P; Laxenaire MC
    Am J Obstet Gynecol; 2002 Mar; 186(3):518-22. PubMed ID: 11904617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous iron in the treatment of anemia of pregnancy. 1949.
    Govan AD; Scott JM
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123 Suppl 2():S33-5. PubMed ID: 16360540
    [No Abstract]   [Full Text] [Related]  

  • 38. Anemia during pregnancy and in the postpartum: intravenous iron therapy revisited.
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123 Suppl 2():S1-35. PubMed ID: 16360535
    [No Abstract]   [Full Text] [Related]  

  • 39. Intravenous iron isomaltoside 1000 administered by high single-dose infusions or standard medical care for the treatment of fatigue in women after postpartum haemorrhage: study protocol for a randomised controlled trial.
    Holm C; Thomsen LL; Norgaard A; Langhoff-Roos J
    Trials; 2015 Jan; 16():5. PubMed ID: 25588587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of total-dose iron sucrose infusions in patients with iron deficiency anemia.
    Wall GC; Pauly RA
    Am J Health Syst Pharm; 2008 Jan; 65(2):150-3. PubMed ID: 18192261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.